Cutaneous vasculitis: a series of 56 patients

Authors

  • Vahideh Lajevardi Department of dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Zahra Hallaji Department of dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Iraj Shekari Array (unauthenticated)
  • Arash Shekari Researcher, Department of dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Maedeh Sharifian Researcher, Department of dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Zohreh Khodashenas Department of dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.66344/jpad.v27i4.941

Keywords:

vasculitis, cutaneous leukocytoclastic vasculitis

Abstract

 

Objective To document the clinical features, type of vasculitis and underlying causative factors in cutaneous vasculitis.

Methods In this retrospective study we reviewed the medical records of 56 patients with biopsy-proven cutaneous vasculitis. Age and sex, age of onset, past medical history, recent drug history, laboratory data, site of involvement, symptoms of lesions and pathological findings.

Results Female patients outnumbered males (35 vs. 21). The mean age of onset was 37.7±18.6 year for women and 41.7±16.4 year for men. Lower extremities were the most frequent affected site (100%). Purpura (58.6%) and papules/plaques (55.4%) were the predominant lesions. The most common type of biopsy proven cutaneous vasculitis was cutaneous leukocytoclastic angiitis followed by vasculitis associated with probable etiology.

 

Conclusion

Females were frequently affected. The disease predominantly affected lower legs as purpuric or papular eruption. Cutaneous leukocytoclastic angiitis and vasculitis associated with probable etiology were the frequent types.

 

References

1. Sneller MC, Langford CA, Fauci AS. The vasculitis syndromes. In: Kasper DL, Braunwald E, Fauci AS, et al. editors. Harrison's Principles of Internal Medicine. 16th edn. New York: McGraw-Hill Medical; 2005. p. 2011.

2. Jennet JC. Overview of the 2012 revised International Chapel Hill Consensus Conference on the nomenclature of vasculitides. Clin Exp Nephrol. 2013;17:603-6.

3. Lotti T, Comacchi C, Ghersetich I. Cutaneous necrotizing vasculitis. Int J Dermatol. 1996;35:457-74.

4. Martinez-Taboada VM, Blanco R, Garcia-Fuentes M, Rodrigues-Valverde V. Clinical features and outcome of 95 patients with hypersensitivity vasculitis. Am J Med. 1997;102:186-91.

5. Blanco R, Martinez-Taboada VM, Rodrigues-Valverde V, Garcia-Fuentes M. Cutaneous vasculitis in children and adults: associated diseases and etiologic factors in 303 patients. Medicine. 1998;77:403-18.

Downloads

Published

27.05.2018

Issue

Section

Original Articles

How to Cite

1.
Cutaneous vasculitis: a series of 56 patients. J Pak Assoc Dermatol [Internet]. 2018 May 27 [cited 2026 Aug. 2];27(4):381-3. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/941